Take the Diabetes Health Pump Survey
Diabetes Health magazine
See What's Inside
Read this FREE issue now
For healthcare professionals only

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
next
Latest
Popular
Top Rated

Latest Byetta Articles

Type 2: Oramed Sends Oral Insulin Test Request to FDA
Lilly Says Its New Injectible Outperforms Three Popular Diabetes Drugs
Lilly Says Its New Injectible Outperforms 3 Popular Diabetes Drugs
Am I Doing the Right Thing?
An Update on Bydureon
FDA Gives Long-Awaited Nod to Amylin’s Bydureon
Sanofi Says Late-Stage Trial of Type 2 Drug a Success
Study Says Byetta and Januvia Do Not Pose Extra Risk for Pancreatitis
FDA Hedges Approval of Long-Acting Byetta, Asks Amylin for More Information
Amylin Hopes to Begin U.S. Sales of Long-Acting Byetta Early This Year
Byetta Archives
Browse the Byetta Archives
Subscribe to the Medications RSS Feed
Print | Email | Share | Comments (0)

Warning About Byetta and Pancreatitis


Nov 5, 2007

The FDA has received thirty reports of acute pancreatitis (rapid-onset inflammation of the pancreas) in type 2 patients taking Byetta. Twenty-seven of the thirty patients had one or more risk factors for acute pancreatitis, such as gallstones or alcohol use.

In six patients, the pancreatitis symptoms began or worsened after the dose of Byetta was doubled. Twenty-two of the thirty improved after discontinuing Byetta, and three worsened again after Byetta was re-started.

As a result of these reports, the FDA is asking Amylin, the drug's maker, to add a warning about pancreatitis to the "Precautions" section of the drug's label. The agency is advising Byetta-taking patients to seek medical care if they have unexplained persistent abdominal pain, possibly accompanied by vomiting. Physicians are also being instructed to discontinue Byetta if pancreatitis is suspected.

* * *

Source: Medpage Today

Categories: Byetta, Medications, Professional Issues, Type 2 Issues, Type 2 Medications

Donate to Diabetes Health

You May Also Be Interested In...

Click Here To View Or Post Comments

Comments 0 comments - Nov 5, 2007

©1991-2013 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.